Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed Still Wants Full Device-Tax Repeal, But Temporary Moratorium Is A Backup

Executive Summary

While the device lobby group says it will continue to fight for a permanent medical device tax repeal over the next three months, it will consider a temporary repeal if Congress doesn't get its "act together."

You may also be interested in...



Patient Advocacy Groups Lobby Congress To Repeal Device Tax

Medical device lobbyists and a significant number of lawmakers have been urging the congressional leadership to step up and help pass a permanent repeal of the medical device tax. Now several patient advocacy groups have waded into the fight to end the tax with just weeks to go before it is set to be reinstituted.

Lawmakers Urge House Speaker To Take Action On Device Tax

With time running out, 179 House lawmakers from across the aisle have written to House Speaker Paul Ryan, R-Wisc., to include medical device tax repeal in bills set to come to the floor for a vote before the year ends.

Committees Vote To Secure Kid's Health Funding, But No Device Tax Relief In Sight

Under the gun and past a deadline, Senate and House authorizing committees managed to advance almost-identical bills extending funding for the US Children's Health Insurance Program (CHIP) to full-chamber votes. But no device tax repeal provisions came up amid other demanding political and fiscal priorities, and a Senate staffer says device-tax repeal may be too expensive.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121538

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel